Evicenter
Ibrance (palbociclib) in HR-positive HER2-negative advanced or metastatic breast cancer
Manufacturer
Pfizer Laboratories Div Pfizer Inc
Questions
28
Last updated

All questions

Indication: Ibrance (palbociclib) in HR-positive HER2-negative advanced or metastatic breast cancer

2 questions · 3 sources